Comparative effectiveness of nafcillin or cefazolin versus vancomycin in methicillin-susceptible Staphylococcus aureus bacteremia

BACKGROUND: The high prevalence of methicillin-resistant S. aureus (MRSA) has led clinicians to select antibiotics that have coverage against MRSA, usually vancomycin, for empiric therapy for suspected staphylococcal infections. Clinicians often continue vancomycin started empirically even when meth...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Schweizer, Marin L, Furuno, Jon P, Harris, Anthony D, Johnson, J Kristie, Shardell, Michelle D, McGregor, Jessina C, Thom, Kerri A, Cosgrove, Sara E, Sakoulas, George, Perencevich, Eli N
Formato: Artigo
Idioma:Inglês
Publicado: BioMed Central 2011
Assuntos:
Research Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC3206863/
https://ncbi.nlm.nih.gov/pubmed/22011388
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2334-11-279
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares